openPR Logo
Press release

Acetazolamide Market Five Years Forecast Skeleton With Key Companies Cadila Healthcare ,Lannett Company, Strides Shasun Limited, and X-GEN Pharmaceuticals,

02-18-2019 01:20 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Acetazolamide

Acetazolamide

The Global Acetazolamide Market, by Formulation (Tablets, Capsules, and Injection), by Application (Glaucoma, Epilepsy, Drug-induced Edema, Altitude Sickness, Fluid Retention, Heart Failure, and Seizures), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued US$ 191.8 million in 2018, and is projected to exhibit a CAGR of 4.8% during the forecast period (2018 - 2026) as highlighted in a new report published by Coherent Market Insights.

The global acetazolamide market is expected to expand at a CAGR of 4.8% during the forecast period (2018 – 2026), owing to high prevalence of glaucoma, edema, and its associated risk factors such as diabetes, family history of glaucoma, high blood pressure, among others.

Among formulation, tablets segment accounted for major market share in 2017. Acetazolamide is majorly used in the treatment of glaucoma and altitude sickness, owing to increasing dosing preference and clinical effectiveness of acetazolamide. For instance, according to data published in the BMJ journal in September 2012, daily doses of 250 mg, 500 mg, and 750 mg acetazolamide was found to be effective in preventing acute mountain sickness.

Get HOLISTIC Request Sample Copy Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/2396

Among applications, glaucoma segment held major market share, in 2017. Acetazolamide is approved and increasingly used as carbonic anhydrase inhibitor in the treatment of glaucoma, by offering substantial pressure relief effect.

Among distribution channel, hospitals pharmacies segment held major market share in 2017. Hospital pharmacies act as key channel in distribution of acetazolamide medication to glaucoma patients who are treated in hospital.

Some of the major players operating in global acetazolamide market include Teva Pharmaceutical Industries Ltd., Accord Healthcare Ltd. (Intas Pharmaceuticals Limited), Heritage Pharmaceuticals Inc., Nostrum Laboratories Inc., Novast Laboratories Ltd., Cadila Healthcare (Zydus Pharmaceuticals (USA) Inc.), Lannett Company, Inc., Strides Shasun Limited, and X-GEN Pharmaceuticals, Inc.

Furthermore, key players are engaged in launching acetazolamide-based products along with gaining regulatory approval for the same in the market.

For instance, in November 2017, Strides Pharma Global Pte. Ltd. — subsidiary of Strides Shasun Limited—received approval from the U.S. Food and Drug Administration (FDA) for acetazolamide tablets, 125 mg and 250 mg, a generic version of Diamox Tablets. Acetazolamide tablet is used to prevent and reduce the symptoms of altitude sickness and treat a certain type of eye problem (open-angle glaucoma). In the U.S., company’s acetazolamide tablets are marketed by Strides Pharma Inc.

Furthermore, in November 2012, Sagent Pharmaceuticals introduced acetazolamide for injection, specified for adjunctive treatment of edema due to congestive heart failure, drug-induced edema, centrencephalic epilepsies, and chronic simple glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/2396

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acetazolamide Market Five Years Forecast Skeleton With Key Companies Cadila Healthcare ,Lannett Company, Strides Shasun Limited, and X-GEN Pharmaceuticals, here

News-ID: 1596104 • Views:

More Releases from Coherent Market Insights

Biological Pesticide Market Report Global Analysis, Statistics & Revenue Research Report by 2024-2031 | Dow Chemicals, Du Pont (EI) de Nemours
Biological Pesticide Market Report Global Analysis, Statistics & Revenue Researc …
The global biological pesticides market size is projected to surpass US$ 6.5 billion by 2027, and register a CAGR of 16.1% over the forecast period (2019 - 2027). The latest report published by Coherent Market Insights offers an in-depth analysis of the global Biological Pesticide Market, with a particular emphasis on high-growth applications in each vertical and rapidly expanding market segment. It presents a detailed competitive landscape, identifying the key players
Agricultural Microbials Market Report [2024-2031] Flourishing Industry Worldwide, Top Countries Insight Revealed | Sumitomo Chemical Co., Ltd., BASF SE
Agricultural Microbials Market Report [2024-2031] Flourishing Industry Worldwide …
The latest report published by Coherent Market Insights offers an in-depth analysis of the global Agricultural Microbials Market, with a particular emphasis on high-growth applications in each vertical and rapidly expanding market segment. It presents a detailed competitive landscape, identifying the key players in each market type, along with an exhaustive market share analysis that covers individual revenue, market shares, and rankings of top players. The report also features an
Contact Lens Market Generated Opportunities, Future Scope 2024-2031 | Novartis International AG, Menicon Group, The Cooper Companies, Inc.
Contact Lens Market Generated Opportunities, Future Scope 2024-2031 | Novartis I …
Coherent Market Insights introduces new research on the Contact Lens Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also focuses
Eclinical Solutions Market Is Booming Worldwide 2024-2031 |  BioClinica Inc., CRF Health, DATATRAK International Inc., eClinical Solutions Inc.
Eclinical Solutions Market Is Booming Worldwide 2024-2031 |  BioClinica Inc., C …
Coherent Market Insights introduces new research on the Eclinical Solutions Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also focuses

All 5 Releases


More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications